Not Tagged
gsk
['sarcoma']
#asco22 11500 - study on #immunotherapy for myxoid/round cell liposarcoma #sarcoma pts by anti-ny-eso-1 #tcr autologous #tcell (lete-cel ). up to 40% of pts responded for median 7.5m. how can we boost responses?vaccination? cytokines?
Cancer specialist searching the world for better therapy